Physician profile
Arnold S Bayer
NPI 1467431981
$1,791.97
in general payments reported to CMS, 2019-2025
11 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $318 · 2020: $106 · 2021: $39.84 · 2022: $96.19 · 2023: $1,217 · 2024: $15.03.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $1,155 · Food and Beverage: $76.57.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $1,155.00 |
| Food and Beverage | $76.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Philips North America LLC | $1,155.00 | 2023 | |
| Merck Sharp & Dohme LLC | $229.64 | 2019-2022 | |
| Astellas Pharma US INC | $88.95 | 2019-2021 | |
| Melinta Therapeutics, LLC | $72.84 | 2019 | |
| Allergan, INC. | $68.15 | 2019-2020 | |
| Tetraphase Pharmaceuticals, INC. | $45.31 | 2019 | |
| Shionogi INC | $37.39 | 2023 | Fetroja |
| Mylan Specialty L.P. | $36.57 | 2019-2020 | |
| Gilead Sciences, INC. | $24.15 | 2023 | |
| Pfizer INC. | $18.94 | 2019 | |
| Viiv Healthcare Company | $15.03 | 2024 | Dovato |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Arnold Bayer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.